Axsome Therapeutics (AXSM) Other Gross PP&E Adjustments: 2022-2025
Historic Other Gross PP&E Adjustments for Axsome Therapeutics (AXSM) over the last 4 years, with Sep 2025 value amounting to -$23.3 million.
- Axsome Therapeutics' Other Gross PP&E Adjustments fell 217.04% to -$23.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$82.4 million, marking a year-over-year decrease of 138.17%. This contributed to the annual value of -$5.4 million for FY2024, which is 20.51% up from last year.
- Per Axsome Therapeutics' latest filing, its Other Gross PP&E Adjustments stood at -$23.3 million for Q3 2025, which was up 9.44% from -$25.7 million recorded in Q2 2025.
- In the past 5 years, Axsome Therapeutics' Other Gross PP&E Adjustments registered a high of -$384,568 during Q3 2022, and its lowest value of -$28.1 million during Q1 2025.
- Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$9.3 million (2024), whereas its average is -$13.0 million.
- In the last 5 years, Axsome Therapeutics' Other Gross PP&E Adjustments plummeted by 2,155.78% in 2023 and then grew by 20.51% in 2024.
- Over the past 4 years, Axsome Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at -$420,000 in 2022, then crashed by 1,512.38% to -$6.8 million in 2023, then climbed by 20.51% to -$5.4 million in 2024, then crashed by 217.04% to -$23.3 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$23.3 million for Q3 2025, versus -$25.7 million for Q2 2025 and -$28.1 million for Q1 2025.